EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,664,000 | +77.0% | 320,753 | +127.8% | 0.00% | +50.0% |
| Q3 2021 | $940,000 | +0.9% | 140,793 | +28.4% | 0.00% | 0.0% |
| Q2 2021 | $932,000 | -31.3% | 109,618 | -28.6% | 0.00% | 0.0% |
| Q1 2021 | $1,356,000 | +73.2% | 153,507 | +140.7% | 0.00% | 0.0% |
| Q4 2020 | $783,000 | +42.9% | 63,770 | -5.5% | 0.00% | +100.0% |
| Q3 2020 | $548,000 | +131.2% | 67,472 | +173.1% | 0.00% | 0.0% |
| Q2 2020 | $237,000 | +127.9% | 24,703 | +61.0% | 0.00% | – |
| Q1 2020 | $104,000 | +73.3% | 15,345 | +179.1% | 0.00% | – |
| Q4 2016 | $60,000 | – | 5,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |